MGC Diagnostics
MGC Diagnostics designs non-invasive cardiorespiratory diagnostic systems and software for hospitals, pulmonary function labs, cardiology, sports medicine, and asthma clinics. It sells hardware (Ultima, Meridian, Platinum Elite, Fenom Flo), the Ascent software platform, and recurring consumables across 45+ countries.
- Company typePrivate
- Founded1977
- HeadquartersSaint Paul, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What MGC Diagnostics does
MGC Diagnostics Corporation is a medical technology company that designs, manufactures, and services non-invasive cardiorespiratory diagnostic systems. Founded in 1977 as Medical Graphics Corporation and headquartered in Saint Paul, Minnesota, the company develops hardware platforms (Ultima Series, Meridian Series, Platinum Elite body plethysmograph, Fenom Flo FeNO monitor, CCM Express indirect calorimeter, NBM 200 hemoglobin monitor) and accessory equipment (Trackmaster treadmills, Lode Corival ergometers, Nonin pulse oximeters, MDI spacers) for pulmonary function testing (PFT), cardiopulmonary exercise testing (CPET), indirect calorimetry, six-minute walk testing, and FeNO measurement. It serves pulmonary function labs, respiratory therapy departments, cardiology and cardiac rehab programs, sports medicine clinics, ICU metabolic assessment, and asthma/allergy practices, with select installations at agencies such as NASA and ESA.
The technical foundation rests on proprietary preVent flow sensor technology (30+ years of development), breath-by-breath gas exchange analysis, and the Ascent software platform that unifies PFT and CPET workflows with HL7/EMR interoperability via AscentConnect, real-time ATS/ERS quality scoring through the Insight gauge, and Microsoft SQL Server networking. Complementary capabilities include SpectOLight occlusion spectroscopy for non-invasive hemoglobin measurement (licensed from OrSense) and the MTI CarePortal cloud platform (HIPAA/HITRUST/GDPR compliant) supporting remote patient monitoring via Bluetooth-connected GoSpiro, GoWeight, GoBlood Pressure, GoPulseOx, glucose, thermometer, and dynamometer devices. ATS/ERS, ISO 13485, ISO 9001, FDA 21 CFR Part 11, and FDA 510(k) compliance underpin the regulatory profile.
MGC makes money through four streams: (1) diagnostic hardware sales (capital equipment); (2) software licenses and subscriptions for Ascent and BreezeSuite; (3) recurring consumables including preVent sensors, DirectConnect metabolic flow sensors, BreathPath patient circuits, face masks, and calibration gases; (4) service contracts (Ultracare), extended warranties, training, and clinical research services. The go-to-market is enterprise field sales to hospitals and clinical labs via wholly-owned subsidiaries in the US, Australia (MGC Diagnostics Australia, formerly Ascencia), Belgium (Medisoft SA), and France (MGC Diagnostics France, formerly MSE Medical), with products deployed across 45+ countries. Pricing is quote-based on capital equipment. Since January 2023, MGC has operated as a wholly-owned subsidiary of CAIRE Inc. (a Niterra subsidiary), following earlier going-private transactions by Altus Capital Partners in 2016.
MGC Diagnostics firmographics
Firmographics- Name
- MGC Diagnostics
- Legal name
- MGC Diagnostics Corporation
- Website
- https://mgcdiagnostics.com
- Company type
- Private
- Founded year
- 1977
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- MGC Diagnostics designs non-invasive cardiorespiratory diagnostic systems and software for hospitals, pulmonary function labs, cardiology, sports medicine, and asthma clinics. It sells hardware (Ultima, Meridian, Platinum Elite, Fenom Flo), the Ascent software platform, and recurring consumables across 45+ countries.
- Ownership category
- akta.pro rank
MGC Diagnostics industry classification
Industry- Product category
- Cardiorespiratory Diagnostic Systems
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)
- akta.pro secondary industries
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)
Keywords
Where MGC Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Saint Paul
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
MGC Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Diagnostic Hardware Systems: Sale of cardiorespiratory diagnostic systems including pulmonary function testing equipment, metabolic stress testing systems, body plethysmographs, spirometers, and exercise testing equipment. Products include Ultima Series, Meridian Series, Platinum Elite, and related peripheral devices.
- Software Licenses and Subscriptions: Ascent and BreezeSuite cardiorespiratory diagnostic software platforms with capabilities for data collection, review, networking, and EMR integration.
- Consumables and Supplies: Proprietary consumables including preVent flow sensors, DirectConnect metabolic flow sensors, BreathPath patient circuits, face masks, mouthpieces, filters, calibration gases, and other testing supplies.
- Service and Support Contracts: Ultracare continuous support service contracts, extended warranties, technical support, training, and professional services for installation and calibration.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | One time/ perpetual license | Cardiorespiratory Diagnostics Seminar - Early Registration |
| One time/ perpetual license | One time/ perpetual license | Cardiorespiratory Diagnostics Seminar - Standard Registration |
| One time/ perpetual license | One time/ perpetual license | Cardiorespiratory Diagnostics Seminar - Late Registration |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
MGC Diagnostics product offering
Product offeringCore offering
MGC Diagnostics develops, manufactures, and sells non-invasive cardiorespiratory diagnostic systems for detecting, classifying, and managing cardiorespiratory disease. The portfolio spans pulmonary function testing equipment, cardiopulmonary exercise testing (CPET/CPX) systems, body plethysmographs, indirect calorimeters, FeNO monitors for asthma management, and non-invasive hemoglobin monitors, integrated through the Ascent software platform with HL7 EMR connectivity. Revenue is generated through hardware sales, software subscriptions, proprietary consumables, and Ultracare service contracts to hospitals and clinical laboratories.
Product overview
MGC Diagnostics is a medical technology company offering a comprehensive portfolio of cardiorespiratory diagnostic systems and software. The product portfolio is organized around a platform-plus-modules architecture centered on the Ascent™ Software Solutions platform, which serves as the unified workflow interface for all diagnostic testing. Core hardware systems include the Ultima Series (CardiO2®, PF, PFX, CPX, CCM) for comprehensive pulmonary function and metabolic testing, the Platinum Elite™ body plethysmograph for lung volume measurements, and the Meridian Series™ (CPX, Cardio2, CCM configurations) as the latest-generation modular diagnostic systems. Specialized devices include FeNO monitoring systems (Fenom Flo™ and Fenom Pro), indirect calorimeters (Ultima CCM™ and CCM Express®), and the NBM 200 non-invasive hemoglobin monitor. Supporting accessories include Nonin pulse oximeters, MDI holding chambers/spacers, RAM treadmills, Lode ergometers (Corival CPET and Recumbent), and Trackmaster treadmills. Remote patient monitoring is supported through the MTI CarePortal™ cloud platform and RPM Connected Devices (GoSpiro spirometer, GoWeight scale, GoBlood Pressure monitor, GoPulseOx, glucose meter, thermometer, hand dynamometer) with Bluetooth connectivity. HL7 interface integration connects diagnostic data to hospital EMR systems.
Differentiator
Problem solved
Functional benefit
Brands
- Ascent: Cardiorespiratory diagnostic software platform combining PFT and CPET testing options
- BreezeSuite
- Ultima Series
- Meridian Series
- Platinum Elite
- Fenom Flo
- CCM Express
- CPFS/D USB
- preVent
Products and services
- Platinum Elite™ Body Plethysmograph Comprehensive body plethysmography system with patented zero-clearance revolving door design, providing the smallest footprint of any body box on the market, unlimited weight capacity, and largest usable patient space. For hospitals and pulmonary function labs performing lung volume measurements.
- Meridian Series™ Cardiorespiratory Diagnostic Systems Modular diagnostic system available in CPX, Cardio2, and CCM configurations that accurately assesses cardiovascular and respiratory function. Redesigned in 2025 with focus on accuracy, precision, and performance for hospitals and clinical diagnostic environments.
- CPFS/D USB™ Spirometer Small, portable full-function spirometer compatible with desktop and laptop computers. USB powered with incentive graphics for pediatric populations. For clinical spirometry in office or lab environments.
- Ultima™ CardiO2® Gas Exchange Analysis System
- Ultima PF™ Pulmonary Function System
- Ultima PFX® Pulmonary Function/Stress Testing System
- Ultima CPX™ Metabolic Stress Testing System
- Ultima CCM™ Indirect Calorimeter
- CCM Express® Indirect Calorimeter
- NBM 200 Non-Invasive Hemoglobin Monitor
- Fenom Flo™ FeNO Monitoring System Handheld portable FeNO device approved for 6-second breath test in adults and pediatric patients ages 7+. Designed for point-of-care use with no daily calibration required and user-replaceable NO sensor. For asthma and allergy management.
- Fenom Pro FeNO Monitor
- Ascent™ Software Solutions Cardiorespiratory diagnostic software platform combining pulmonary function testing (PFT) and cardiopulmonary exercise testing (CPET) in one solution. Features AscentReview physician review software and AscentConnect HL7 interface for EMR integration.
- MTI CarePortal™ Remote Patient Monitoring Platform
- Trackmaster TMX 428 Treadmill
- RAM Treadmills
- Corival CPET Ergometer
- Corival Recumbent CPET Ergometer
Quantifiable outcome
- COPD affects over 300 million people worldwide and is the third leading cause of death globally
- +1 more outcomes
Companies that use MGC Diagnostics
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles3 records
MGC Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration13 records
AI capability2 records
Feature10 records
MGC Diagnostics partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- MSE MedicalcoreAcquisition of France-based MSE Medical in 2019 expanded French market and resulted in MGC Diagnostics France entity.
- AscenciacoreAcquisition of Australia-based Ascencia in 2019 expanded South Pacific market and resulted in MGC Diagnostics Australia entity.
- Medisoft SAcoreAcquisition of Belgium-based Medisoft SA in 2013 significantly expanded MGC Diagnostics business internationally, adding Body 5500 device and European market presence.
- Mortara Instrument, Inc.coreMortara provides 12-lead ECG technology integrated into Ultima CardiO2 systems. Mortara is described as the world leader in ECG technology with automated arrhythmia detection and event marking capabilities.
- Nonin MedicalcoreNonin Medical provides WristOx2 3150 Bluetooth Pulse Oximeter integrated with MGC Diagnostics cardiorespiratory diagnostic software for Six Minute Walk Testing. Pulse oximeter data is captured seamlessly within BreezeSuite and Ascent software.
Scale indicators4 records
Recent moves11 records
Expansion highlights5 records
MGC Diagnostics competitors and assessment
Company assessmentDirect peers
- COSMED: Italy-based manufacturer of cardiopulmonary exercise testing (CPET), metabolic assessment, and body composition equipment. Directly competes with MGC's Ultima CPX and Meridian Series CPX/CardiO2 systems for hospital and sports medicine customers.
- Vyaire Medical: Respiratory diagnostics and ventilation company (formerly CareFusion/BD respiratory segment) offering pulmonary function testing, body plethysmography, and metabolic measurement systems. Direct competitor to MGC across the hospital pulmonary function lab.
- Schiller AG: Swiss manufacturer of cardiopulmonary diagnostics including ECG, stress testing, and pulmonary function equipment. Directly comparable to MGC's Ultima CardiO2 stress testing systems and integrated PFT/CPET offerings.
- ndd Medical Technologies: Switzerland-based company specializing in ultrasonic spirometry and pulmonary function testing equipment. Directly competes with MGC's spirometers (CPFS/D USB) and PFT systems in the same pulmonology and primary care channels.
Broad incumbents
- GE Healthcare: Global medical technology incumbent offering ECG, stress testing, patient monitoring, and anesthesia delivery that overlap with MGC's cardiorespiratory diagnostics from a much broader hospital capital equipment portfolio.
- Hillrom (Baxter): Now part of Baxter, Hillrom's diagnostics and patient support portfolio includes ECG and vital signs monitoring that overlap with the Mortara-powered components within MGC's Ultima CardiO2 systems.
- Philips Respironics: Broad respiratory care and sleep diagnostics franchise within Philips that overlaps with MGC's respiratory testing and RPM offerings as part of a larger hospital portfolio rather than a focused cardiorespiratory niche.
Emerging players
- Morgan Scientific: US-based specialist in pulmonary function testing, spirometry, and respiratory diagnostics. Smaller competitor with overlap on PFT systems (similar to MGC's Ultima PF and Platinum Elite) targeting hospital and occupational health segments.
- Bertin Technologies: European provider of physiological monitoring and respiratory instrumentation including exhaled nitric oxide (FeNO) measurement. Closely comparable to MGC's Fenom Flo FeNO platform in the asthma and respiratory diagnostics workflow.
- Nonin Medical: US-based pulse oximetry specialist supplying the WristOx2 3150 integrated into MGC's BreezeSuite and Ascent software. Now led by MGC's former president/CEO Todd Austin, making it both an existing technology partner and an emerging adjacent competitor in respiratory monitoring.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
MGC Diagnostics social profiles
Digital presenceMGC Diagnostics compliance and trust
Trust signalCompliance6 records
MGC Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
MGC Diagnostics leadership team
Management profileNumber of profiles
Profiles2 records
MGC Diagnostics subsidiaries and ownership
Company hierarchySubsidiaries5 records
MGC Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MGC Diagnostics M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MGC Diagnostics
What does MGC Diagnostics do?
MGC Diagnostics develops, manufactures, and sells non-invasive cardiorespiratory diagnostic systems for detecting, classifying, and managing cardiorespiratory disease. The portfolio spans pulmonary function testing equipment, cardiopulmonary exercise testing (CPET/CPX) systems, body plethysmographs, indirect calorimeters, FeNO monitors for asthma management, and non-invasive hemoglobin monitors, integrated through the Ascent software platform with HL7 EMR connectivity. Revenue is generated through hardware sales, software subscriptions, proprietary consumables, and Ultracare service contracts to hospitals and clinical laboratories.
Is MGC Diagnostics a public or private company?
MGC Diagnostics is a private company. It is classified as corporate owned and is currently operating.
When was MGC Diagnostics founded?
MGC Diagnostics was founded in 1977. It employs 101 to 250 people.
Where is MGC Diagnostics based?
MGC Diagnostics is headquartered in Saint Paul, United States, in the North America region.
How does MGC Diagnostics make money?
Four revenue lines are on record. Diagnostic Hardware Systems are the primary driver. The others are software Licenses and Subscriptions, consumables and Supplies and service and Support Contracts.
Who are MGC Diagnostics's main competitors?
Direct peers on record are COSMED, Vyaire Medical, Schiller AG and ndd Medical Technologies. Broad incumbents are GE Healthcare, Hillrom (Baxter) and Philips Respironics. Emerging players are Morgan Scientific, Bertin Technologies and Nonin Medical.
Does MGC Diagnostics have an API?
No public API is recorded for MGC Diagnostics.
What industry is MGC Diagnostics in?
MGC Diagnostics's product category is Cardiorespiratory Diagnostic Systems. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 334516 and its SIC code is 3841.